Compare General Mills, Inc. (GIS) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Mills, Inc. vs Hinge Health Inc. Class A Common Stock — how do they compare? General Mills, Inc. trades at $32.5 (market cap $17.02B), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: General Mills, Inc. is far larger — about 2× Hinge Health Inc. Class A Common Stock's market cap, and General Mills, Inc. pays a 7.67% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Mills, Inc. for 107 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| GIS | HNGE | |
|---|---|---|
Market Cap | $17.02B | $8.48B |
Volume | 7,979,067 | 879,799 |
Sector | Consumer Staples | Health |
52-Week High | $49.18 | $105.14 |
52-Week Low | $31.67 | $31.17 |
Typical Hold Time | 107 Days | 0 Days |
Enterprise Value | $30.20B | $8.10B |
Dividend Yield | 7.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Mills (GIS) trades at $32.11, down 1.8% on the day, reflecting recent pressure from a Q4 2025 earnings miss and a projected net loss for 2026. The stock shows a bearish technical trend, with key support at $32. Despite a low P/E of 9.23, profitability metrics like a negative ROE of -10.55% and a forecasted negative net income margin for 2026 highlight significant challenges. Recent news includes a CEO transition and a reaffirmed $0.61 quarterly dividend, but investor sentiment remains cautious amid declining revenues and margin pressures.
The outlook for GIS is clouded by execution risks in its turnaround strategy and macroeconomic headwinds. The high dividend yield offers income appeal, but the potential for a dividend cut and sustained earnings weakness presents substantial risk. Analyst consensus is predominantly Hold, with a $36 price target suggesting limited near-term upside, making the stock a speculative hold for income-focused investors tolerant of high risk.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Read more on GIS →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
